Frontline Immunotherapy in Advanced Bladder Cancer – OncLive
OncLive |
Frontline Immunotherapy in Advanced Bladder Cancer
OncLive Daniel J. George, MD: For our patients who are, say, cisplatin-ineligible but maybe aren't quite as symptomatic, maybe then I'm more concerned about their long-term tolerance to chemotherapy. I'm worried about maybe some other complications associated … |
